European Journal of Skin Cancer Editorial by Dirk Schadendorf, Celeste Lebbe, Paul Lorigan, Susana Puig

Get full text

Psychological Factors Influencing Appropriate Reliance on AI-enabled Clinical Decision Support Systems: Experimental Web-Based Study Among Dermatologists by Alisa Küper, Georg Christian Lodde, Elisabeth Livingstone, Dirk Schadendorf, Nicole Krämer

Get full text

Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma by Alpaslan Tasdogan, MD, PhD, Dirk Schadendorf, MD, Selma Ugurel, MD

Get full text

Comparative analysis of international melanoma guidelines by Ahmad Idrissi-Yaghir, Henning Schäfer, Hendrik Damm, Georg C. Lodde, Elisabeth Livingstone, Dirk Schadendorf, Christoph M. Friedrich

Get full text

The Mappability of Clinical Real-World Data of Patients with Melanoma to Oncological Fast Healthcare Interoperability Resources (FHIR) Profiles: A Single-Center Interoperability St... by Jessica Swoboda, Moritz Albert, Catharina Lena Beckmann, Georg Christian Lodde, Elisabeth Livingstone, Felix Nensa, Dirk Schadendorf, Britta Böckmann

Get full text

PTHrP-induced hypercalcemic psychosyndrome under combined anti-PD-L1 and anti-EGFR inhibition in penile squamous cell carcinoma – A case report by Lea Jessica Albrecht, Viktor Grünwald, Jürgen C. Becker, Ralf Gutzmer, Livia Asan, Ellen Uslar, Alexandra Eilers, Anne-Christine Müseler, Alexander Roesch, Dirk Schadendorf, Lisa Zimmer, Elisabeth Livingstone

Get full text

Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab. by Dagmar von Bubnoff, Christina Schmitt, Simone M Goldinger, Dirk Schadendorf, Katharina C Kähler, Christian Hafner, Nora Kramer, Waltraud Fröhlich, Reinhard Dummer, Carola Berking, Stefan Schliep, Michael C Kirchberger, Lucie Heinzerling

Get full text

BioKGrapher: Initial evaluation of automated knowledge graph construction from biomedical literature by Henning Schäfer, Ahmad Idrissi-Yaghir, Kamyar Arzideh, Hendrik Damm, Tabea M.G. Pakull, Cynthia S. Schmidt, Mikel Bahn, Georg Lodde, Elisabeth Livingstone, Dirk Schadendorf, Felix Nensa, Peter A. Horn, Christoph M. Friedrich

Get full text

Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients by Katarzyna Borys, Georg Lodde, Elisabeth Livingstone, Carsten Weishaupt, Christian Römer, Marc-David Künnemann, Anne Helfen, Lisa Zimmer, Wolfgang Galetzka, Johannes Haubold, Christoph M. Friedrich, Lale Umutlu, Walter Heindel, Dirk Schadendorf, René Hosch, Felix Nensa

Get full text

Correction: Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients by Katarzyna Borys, Georg Lodde, Elisabeth Livingstone, Carsten Weishaupt, Christian Römer, Marc-David Künnemann, Anne Helfen, Lisa Zimmer, Wolfgang Galetzka, Johannes Haubold, Christoph M. Friedrich, Lale Umutlu, Walter Heindel, Dirk Schadendorf, René Hosch, Felix Nensa

Get full text

Sonidegib reduced tumor burden in patients with advanced basal cell carcinoma in the BOLT trial: Long-term analysis results by Michael R. Migden, Aaron S. Farberg, James Spencer, Felix Kiecker, Alexander Guminski, Kurt Gebauer, Carmen Loquai, Caroline Robert, Reinhard Dummer, Dirk Schadendorf, Axel Hauschild, Jean Jacques Grob, Nicholas Squittieri, Ramon Arntz, Serena Martelli, Joerg Dierlamm, Ralf Gutzmer

Get full text

Identification and characterization of tertiary lymphoid structures in brain metastases by Sadaf S. Mughal, Yvonne Reiss, Jörg Felsberg, Lasse Meyer, Jadranka Macas, Silja Schlue, Tatjana Starzetz, Karl Köhrer, Tanja Fehm, Volkmar Müller, Katrin Lamszus, Dirk Schadendorf, Iris Helfrich, Harriet Wikman, Anna Berghoff, Benedikt Brors, Karl H. Plate, Guido Reifenberger

Get full text

RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melan... by Sara Egea‐Rodriguez, Renáta Váraljai, Thierry M. Nordmann, Restuan Lubis, Manuel Philip, Florian Rambow, Alexander Roesch, Michael Flaig, Susanne Horn, Raphael Stoll, Fang Zhao, Annette Paschen, Bert Klebl, Ian D. Hickson, Dirk Schadendorf, Matthias Mann, Iris Helfrich

Get full text

Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment by Michael Weichenthal, Inge Marie Svane, Johanna Mangana, Ulrike Leiter, Friedegund Meier, Christina Ruhlmann, Dimitrios Ziogas, Reinhard Dummer, Pablo Cerenzuela, Jose Luis Manzano, Marc Bender, Shan Jiang, Paolo Antonio Ascierto, Iva Gavrilova, Lidija Kandolf, Helen Gogas, Peter Mohr, Dirk Schadendorf, Eva Ellebaek

Get full text

Impact of osteoprotective therapies on the efficacy of immune checkpoint inhibition in melanoma patients – A multicentre study from the prospective skin cancer registry ADOReg by Corinna Kochanek, Katrin Schaper-Gerhardt, Lisa Zimmer, Selma Ugurel, Friedegund Meier, Peter Mohr, Patrick Terheyden, Sebastian Haferkamp, Martin Kaatz, Michael Sachse, Frank Meiss, Claudia Pföhler, Ulrike Leiter, Jens Ulrich, Dirk Schadendorf, Michael Weichenthal, Imke von Wasielewski, Yenny Angela, Ralf Gutzmer

Get full text

Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct by Dirk Schadendorf, Peter Martus, Stephan Zipfel, Yesim Erim, Alexander Bäuerle, Martin Teufel, Caterina Schug, Johanna Graf, Wolfgang Bethge, Andreas Dinkel, Anja Neumann, Jasmin Steinbach, Jana Heinen, Julia Barbara Krakowczyk, Mirjam Damerau, Sebastian Dries, Anja Mehnert-Theuerkauf, Mitra Tewes, Jörg Wiltink, Alexander Wünsch

Get full text

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors by Dirk Schadendorf, Ignacio Melero, Robert L Ferris, William Sharfman, Satyendra Suryawanshi, Jaclyn Neely, Fabrice Barlesi, Dung T Le, Jason J Luke, Patrick A Ott, Tina Cascone, Nikhil I Khushalani, Abanti Sanyal, Scott Ely, Manish R Sharma, Deanne Lathers, James L Holloway, Rasika Suryawanshi, Neil H Segal

Get full text

Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716... by Dirk Schadendorf, Caroline Robert, Reinhard Dummer, Luis de la Cruz-Merino, Paolo A Ascierto, John M Kirkwood, Georgina V Long, Jacek Mackiewicz, Richard A Scolyer, Piotr Rutkowski, Jean-Jacques Grob, Jason John Luke, Michele Del Vecchio, Mizuho Kalabis, Adnan Khattak, Matteo S Carlino, Yujie Zhao, Alexander Eggermont, Vanna Chiarion Sileni, Clemens Krepler

Get full text

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy by Dirk Schadendorf, Celeste Lebbe, Teresa Amaral, Benjamin Weide, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Reinhard Dummer, Domenico Mallardo, Paolo A Ascierto, Piotr Rutkowski, Jason John Luke, Kilian Wistuba-Hamprecht, Mitchell P Levesque, Roberta Turiello, Elva Morretta, Maria Chiara Monti, Rosa Azzaro, Laurence Imhof, Marc Chevrier, Antje Sucker, Aldo Pinto, Silvana Morello

Get full text

Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic by Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H. Brandts, Peter Brossart, Sara Yvonne Brucker, Tim H. Brümmendorf, Hartmut Döhner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann

Get full text